THE INVESTOR

메뉴열기
May 27, 2019

NPS to oppose Samsung Biologics’ proposals for shareholders meeting

PUBLISHED : March 21, 2019 - 16:02

UPDATED : March 21, 2019 - 16:02

  • 본문폰트 작게
  • 본문폰트 크게
  • 페이스북
  • 트위터
  • sms

National Pension Service has decided to oppose key proposals by Samsung Biologics ahead of the company’s scheduled shareholders meeting on March 22.

The key proposals include approval of the financial statement and appointment of inside and outside executives. 



After having a meeting on March 20, NPS’s Global Responsible Investment & Governance Division, which is responsible for the pension fund’s stewardship code, decided to turn down all the company’s proposals citing the Financial Services Commission’s ruling that Samsung BioLogics intentionally violated accounting rules ahead of its initial public offering in 2016. The case has been referred to the prosecution.


The NPS, which vowed to adopt the stewardship code from July last year, also opposed the reappointment of incumbent CFO Kim Dongjoong and other two outside directors saying that they have a history of hurting the company’s value and shareholders’ interests.

By Park Ga-young (
gypark@heraldcorp.com)

  • 페이스북
  • 트위터
  • sms
최상단으로
Herald Corporation|CEO : Kwon Chung Won
Chief Privacy Officer & Juvenile Protection Manager : Yang Sung-jin
Company Registration No. 104-81-06004
Mail-Order Business Registration 2016 - Seoul Yongsan - 00590
Huam-ro 4-gil 10, Yongsan-gu, Seoul, Korea
T : +82-2-727-0114|Business info
Gov’t registration No. 아 04099
COPYRIGHT HERALD CORPORATION. ALL RIGHTS RESERVED.